Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
marco.salvetti@uniroma1.it
Marco Salvetti
Professore Ordinario
Struttura:
DIPARTIMENTO DI NEUROSCIENZE, SALUTE MENTALE E ORGANI DI SENSO
E-mail:
marco.salvetti@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Environmental modifiable risk factors for multiple sclerosis. Report from the 2016 Ectrims focused workshop
MULTIPLE SCLEROSIS
2018
Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis. An Italian, Multicenter, Real-World Study
CNS DRUGS
2018
Evaluation woes. Start right
NATURE
2018
Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosis
JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY
2018
Analysis of coding and non-coding transcriptome of peripheral B cells reveals an altered interferon response factor (IRF)-1 pathway in multiple sclerosis patients
JOURNAL OF NEUROIMMUNOLOGY
2018
070 Baseline characteristics and safety profile of patients with relapsing-remitting multiple sclerosis (RRMS) in the first interim analysis of the peginterferon BETA-1A treatment in the phase 4 plegridy observational program (POP)
JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY
2018
The Italian multiple sclerosis register
NEUROLOGICAL SCIENCES
2018
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study
JOURNAL OF NEUROLOGY
2018
Bridging the gap between vaccination with Bacille Calmette-Guérin (BCG) and immunological tolerance: the cases of type 1 diabetes and multiple sclerosis
CURRENT OPINION IN IMMUNOLOGY
2018
A Perspective of Coagulation Dysfunction in Multiple Sclerosis and in Experimental Allergic Encephalomyelitis
FRONTIERS IN NEUROLOGY
2018
No evidence of beneficial effects of plasmapheresis in natalizumab-associated PML
NEUROLOGY
2017
A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials
SCIENTIFIC REPORTS
2017
Thymosin-α1 expands deficient IL-10-producing regulatory B cell subsets in relapsing-remitting multiple sclerosis patients
MULTIPLE SCLEROSIS
2017
Coincident onset of multiple sclerosis and herpes simplex virus 1 encephalitis. a case report
MULTIPLE SCLEROSIS AND DEMYELINATING DISORDERS
2017
Chemical Elements and Oxidative Status in Neuroinflammation
Biometals in Neurodegenerative Diseases. Mechanisms and Therapeutics
2017
Immunometabolic profiling of T cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respiration
METABOLISM, CLINICAL AND EXPERIMENTAL
2017
The still under-investigated role of cognitive deficits in PML diagnosis
MULTIPLE SCLEROSIS AND DEMYELINATING DISORDERS
2017
Transcriptional dysregulation of Interferome in experimental and human Multiple Sclerosis
SCIENTIFIC REPORTS
2017
Evidence for detrimental cross interactions between reactive oxygen and nitrogen species in Leber's hereditary optic neuropathy cells
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
2016
Noise Enhances Action Potential Generation in Mouse Sensory Neurons via Stochastic Resonance
PLOS ONE
2016
« prima
< precedente
1
2
3
4
5
6
7
8
9
seguente ›
ultima »
Progetti di Ricerca
Looking for final effectors of regulome alterations in MS: LMP1-mediated dysregulation of AID in MS pathogenesis
Epstein-Barr virus genotypes in multiple sclerosis
Impact of genetic and non-genetic risk factors for MS on regulatory RNAs.
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma